Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ZENA
ZENA logo

ZENA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy ZenaTech Inc (ZENA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.990
1 Day change
-2.93%
52 Week Range
7.110
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

ZenaTech Inc (ZENA) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown significant revenue growth and a positive acquisition move, the technical indicators, options data, and lack of strong trading signals suggest a cautious approach. The stock's bearish moving averages and neutral RSI indicate no clear upward momentum, and the absence of strong Intellectia Proprietary Trading Signals further supports a hold decision.

Technical Analysis

The MACD is slightly positive but contracting, indicating weak momentum. The RSI is neutral at 44.383, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels are Pivot: 2.177, R1: 2.324, S1: 2.03, R2: 2.415, S2: 1.939, suggesting limited upside potential in the short term.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate a bullish sentiment in the options market. However, implied volatility is high at 164.5%, which suggests significant uncertainty.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
2

Positive Catalysts

  • ZenaTech's acquisition of a 10% stake in Route1 Inc. could be a strategic move for long-term growth. The company's revenue growth of 1225.31% YoY in Q3 2025 is impressive.

Neutral/Negative Catalysts

  • Technical indicators do not show strong upward momentum, and there are no recent congress trading data or strong trading signals.

Financial Performance

In Q3 2025, ZenaTech reported a 1225.31% YoY increase in revenue to $4,345,408. Net income improved by 1683.55% YoY but remains negative at -$12,271,924. EPS increased by 750% YoY to -0.34, and gross margin remained stable at 100%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes available for ZenaTech Inc.

Wall Street analysts forecast ZENA stock price to rise
1 Analyst Rating
Wall Street analysts forecast ZENA stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.050
sliders
Low
7
Averages
7
High
7
Current: 2.050
sliders
Low
7
Averages
7
High
7
Citi
Buy
maintain
$46
AI Analysis
2025-12-22
Reason
Citi
Price Target
$46
AI Analysis
2025-12-22
maintain
Buy
Reason
Citi added an "upside 90-day catalyst watch" on shares of Zenas BioPharma while keeping a Buy rating on the shares with a $46 price target ahead of the early January Phase 3 INDIGO readout in immunoglobulin G4-related disease. Citi believes obexlimab is positioned to show a statistically significant reduction in flares relative to placebo.
Maxim
NULL -> Buy
initiated
$9
2025-06-17
Reason
Maxim
Price Target
$9
2025-06-17
initiated
NULL -> Buy
Reason
Maxim initiated coverage of ZenaTech with a Buy rating and $9 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ZENA
Unlock Now

People Also Watch